Charles Schwab Investment Management Inc. Boosts Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Charles Schwab Investment Management Inc. lifted its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 8.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 290,656 shares of the company’s stock after purchasing an additional 22,263 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Phibro Animal Health were worth $6,104,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Rhumbline Advisers lifted its stake in Phibro Animal Health by 0.6% in the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC increased its holdings in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares during the period. BNP Paribas Financial Markets increased its holdings in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the period. New York State Teachers Retirement System raised its position in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after buying an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after buying an additional 906 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $22.06 on Tuesday. The business’s 50-day moving average price is $22.71 and its 200-day moving average price is $22.65. The firm has a market capitalization of $893.50 million, a PE ratio of 45.96, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. Phibro Animal Health Co. has a 12 month low of $12.14 and a 12 month high of $26.55. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Sell-side analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.18%. Phibro Animal Health’s payout ratio is 100.00%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on PAHC. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday, March 15th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.